Hello Nancy,
It is feasible, though generally frowned upon by regulatory agencies. The reason being is when having multiple indications in the Instructions for Use (IFU) could lead to other person in different jurisdictions using the product "off label". If there maybe is some minor differences say in population it might be ok, but getting "acceptance" from regulatory agency would probably be not successful as they are specific on the indications for use. You would also want to use caution because if this is done and a regulatory agency has an issue with this, due to labelling, could result in a field correction or recall.
------------------------------
Richard Vincins ASQ-CQA, MTOPRA, RAC
Vice President Global Regulatory Affairs
Oriel STAT A MATRIX - ENTERPRISE
------------------------------
Original Message:
Sent: 12-Dec-2023 14:19
From: Nancy Zwiep
Subject: multiple indications of use in the same IFU
Is it feasible to create a single Instructions for Use (IFU) document that caters to different markets, each with distinct indications of use? For instance: This product is intended for professional use only in Canada and for insurance and employment use only in the United States.
------------------------------
Nancy Zwiep
Regulatory Affairs Manager
Barrie ON
Canada
------------------------------